EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 253 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,455,166 | -14.6% | 1,310,343 | +84.7% | 0.00% | 0.0% |
| Q2 2023 | $5,214,847 | -18.4% | 709,503 | +15.1% | 0.00% | 0.0% |
| Q1 2023 | $6,388,587 | +138.7% | 616,659 | +172.1% | 0.00% | 0.0% |
| Q4 2022 | $2,676,217 | -79.2% | 226,606 | -63.0% | 0.00% | -66.7% |
| Q3 2022 | $12,845,000 | +86.3% | 611,984 | +175.5% | 0.00% | +200.0% |
| Q2 2022 | $6,894,000 | -12.3% | 222,111 | +16.0% | 0.00% | 0.0% |
| Q1 2022 | $7,862,000 | +40.7% | 191,474 | +48.9% | 0.00% | – |
| Q4 2021 | $5,589,000 | -64.0% | 128,571 | -58.5% | 0.00% | -100.0% |
| Q3 2021 | $15,506,000 | -8.0% | 309,678 | +15.7% | 0.00% | -50.0% |
| Q2 2021 | $16,853,000 | +1.7% | 267,562 | +50.1% | 0.00% | 0.0% |
| Q1 2021 | $16,565,000 | +10.1% | 178,291 | +6.1% | 0.00% | 0.0% |
| Q4 2020 | $15,051,000 | +55.9% | 167,975 | +79.8% | 0.00% | +33.3% |
| Q3 2020 | $9,656,000 | +115.2% | 93,441 | +64.7% | 0.00% | +200.0% |
| Q2 2020 | $4,487,000 | -51.1% | 56,746 | -64.2% | 0.00% | -75.0% |
| Q1 2020 | $9,169,000 | +8.7% | 158,475 | +1.3% | 0.00% | +33.3% |
| Q4 2019 | $8,437,000 | +174.6% | 156,390 | +166.1% | 0.00% | +200.0% |
| Q3 2019 | $3,072,000 | -30.1% | 58,763 | -35.4% | 0.00% | -50.0% |
| Q2 2019 | $4,394,000 | -23.0% | 90,949 | -19.4% | 0.00% | -33.3% |
| Q1 2019 | $5,705,000 | +75.3% | 112,907 | +105.6% | 0.00% | +200.0% |
| Q4 2018 | $3,254,000 | -53.2% | 54,915 | -48.0% | 0.00% | -66.7% |
| Q3 2018 | $6,951,000 | +250.9% | 105,582 | +169.1% | 0.00% | +200.0% |
| Q2 2018 | $1,981,000 | +74.4% | 39,233 | +81.9% | 0.00% | – |
| Q1 2018 | $1,136,000 | +38.7% | 21,564 | +22.3% | 0.00% | – |
| Q4 2017 | $819,000 | -7.9% | 17,626 | -19.8% | 0.00% | -100.0% |
| Q3 2017 | $889,000 | -81.0% | 21,977 | -84.0% | 0.00% | -75.0% |
| Q2 2017 | $4,670,000 | +47.8% | 137,724 | +26.6% | 0.00% | +33.3% |
| Q1 2017 | $3,159,000 | -0.8% | 108,761 | +12.2% | 0.00% | 0.0% |
| Q4 2016 | $3,184,000 | +40.5% | 96,955 | +34.9% | 0.00% | +50.0% |
| Q3 2016 | $2,266,000 | +440.8% | 71,882 | +382.8% | 0.00% | – |
| Q2 2016 | $419,000 | -91.5% | 14,889 | -89.0% | 0.00% | -100.0% |
| Q1 2016 | $4,937,000 | +3584.3% | 135,816 | +3955.4% | 0.01% | – |
| Q4 2015 | $134,000 | -74.7% | 3,349 | -82.0% | 0.00% | -100.0% |
| Q3 2015 | $530,000 | -9.1% | 18,612 | +5.3% | 0.00% | 0.0% |
| Q2 2015 | $583,000 | -83.8% | 17,671 | -85.9% | 0.00% | -66.7% |
| Q1 2015 | $3,601,000 | +91.8% | 125,228 | +81.7% | 0.00% | +50.0% |
| Q4 2014 | $1,877,000 | -29.6% | 68,916 | -45.0% | 0.00% | -33.3% |
| Q3 2014 | $2,668,000 | +942.2% | 125,228 | +1000.4% | 0.00% | – |
| Q2 2014 | $256,000 | -89.4% | 11,380 | -88.1% | 0.00% | -100.0% |
| Q1 2014 | $2,418,000 | +115.5% | 95,662 | +95.9% | 0.00% | +200.0% |
| Q4 2013 | $1,122,000 | +6.9% | 48,826 | -11.4% | 0.00% | -50.0% |
| Q3 2013 | $1,050,000 | -22.7% | 55,100 | -41.5% | 0.00% | 0.0% |
| Q2 2013 | $1,359,000 | – | 94,209 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 2,080,519 | $44,336,000 | 4.65% |
| GREAT POINT PARTNERS LLC | 290,000 | $6,180,000 | 2.65% |
| FIDUCIARY MANAGEMENT ASSOCIATES LLC | 651,884 | $13,892,000 | 0.99% |
| Matarin Capital Management, LLC | 85,003 | $1,811,414,000 | 0.83% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 407,000 | $8,673,000 | 0.39% |
| ICON ADVISERS INC/CO | 258,478 | $5,508,000 | 0.32% |
| RMB Capital Management, LLC | 178,204 | $3,798,000 | 0.23% |
| NEW AMSTERDAM PARTNERS LLC/NY | 159,470 | $3,398,000 | 0.23% |
| GLOBEFLEX CAPITAL L P | 94,016 | $2,003,000 | 0.23% |
| Convergence Investment Partners, LLC | 58,672 | $1,250,000 | 0.17% |